drugset / Trial / NCT01335581

Study of Laser Treatment of Melasma

NCT01335581

Completed 18 enrolled ConBio, a Cynosure Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the RevLite laser in the treatment of refractory mixed type melasma.

Timeline

Start
2011-04
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Background Tretinoin Small molecule

Indications